July 26, 2021

Allergic reaction to first dose of an mRNA COVID-19 vaccine should not keep people from getting the second dose: study

An immediate allergic reaction to the first dose of an mRNA COVID-19 vaccine — those manufactured by Moderna and Pfizer BioNTech — should not keep people from getting the second dose, a multi-hospital analysis shows.

By Nancy Humphrey